Alnylam Pharmaceuticals, Inc. (ALNY)

165.04 USD+5.36%close 2026-11-13Healthcare
Gurus hold2popularity #477 of 1921
Net buying (quarter)−$8.4M1 buying · 1 selling
Market Cap$22.11B52 Week Range: 151.64 – 473.29
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.70.83EPS 2.33
The live quote provider is unreachable; the last known close is shown.

Alnylam Pharmaceuticals, Inc. (ALNY) is not among the 30 most-held stocks of the tracked superinvestor set. Price 165.04 USD; market cap $22.11B.

Guru Ownership

Popularity rank#477 of 1,921 securities
gurus hold it2
Net activity this quarter−$8.4M

Guru count: the consensus-panel funds (wide books such as Citadel or Renaissance excluded) holding the stock at quarter end; the header and the history table use the same definition.

What changed this quarter
$7.9M · 0 new buys · 1 added $16.2M · 1 reduced · 0 sold out1 net buyers · 1 net sellers
Top 5 by conviction
Baillie Gifford0.7%Reduced -2.2%
Dodge & Cox0.3%Added +1.4%
Top 5 by value
Baillie Gifford$734.5MReduced -2.2%
Dodge & Cox$588.6MAdded +1.4%
Ownership by quarter · 72 funds with stored history
Report forgurus hold itTotal ValueAvg Weight
2016-12-313$473.5M0.7%
2017-03-314$654.2M0.2%
2017-06-305$1.01B0.2%
2017-09-303$1.48B0.5%
2017-12-313$1.50B0.5%
2018-03-313$1.02B0.3%
2018-06-303$877.1M0.3%
2018-09-302$798.0M0.4%
2018-12-312$688.1M0.4%
2019-03-312$998.3M0.5%
2019-06-303$834.1M0.3%
2019-09-302$1.09B0.6%
2019-12-313$1.56B0.6%
2020-03-313$1.51B1.1%
2020-06-303$2.03B1.1%
2020-09-303$2.03B1.0%
2020-12-312$1.79B0.6%
2021-03-312$2.03B0.6%
2021-06-302$2.65B0.7%
2021-09-302$2.98B0.8%
2021-12-312$2.72B0.8%
2022-03-313$2.56B0.7%
2022-06-302$2.22B1.0%
2022-09-303$2.90B1.2%
2022-12-313$3.35B1.4%
2023-03-312$2.51B1.1%
2023-06-302$2.31B0.9%
2023-09-302$2.11B0.9%
2023-12-312$2.04B0.8%
2024-03-312$1.56B0.6%
2024-06-302$2.38B0.8%
2024-09-302$2.34B0.8%
2024-12-312$1.78B0.6%
2025-03-313$1.91B0.5%
2025-06-302$2.03B0.7%
2025-09-303$2.33B0.5%
2025-12-312$1.82B0.6%
2026-03-312$1.46B0.6%
2026-06-302$1.32B0.5%

Price & valuation

Prev Close156.64
Open—
Day Range—
52 Week Range151.64 – 473.29
Volume—
Avg Volume (3M)—
Market Cap$22.11BSEC 10-Q, 10/23/2026
BetaVolatility vs the market. Above 1: swings harder than the index.0.942 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.70.83SEC 10-K, 12/31/2025 · fiscal year
EPS (TTM)Annual net profit per share.2.33SEC 10-K, 12/31/2025 · fiscal year
Dividend YieldAnnual dividend over share price.—

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

About

SectorHealthcare
Industry—
Employees—
Website—

Frequently Asked Questions

Which superinvestors own ALNY?

Alnylam Pharmaceuticals, Inc. (ALNY) is not among the 30 most-held stocks of the tracked superinvestor set.

Is institutional sentiment on ALNY bullish or bearish?

ALNY is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.